Weekly Roundup: May 25-29

May 29, 2020
Morgan Petronelli

To keep you up to date with the industry’s latest, we’ve gathered together stories from this week involving glycolic-salicylic acid serum, pediatric multisystem inflammatory syndrome, FDA approvals for dupilumab and minocycline, the latest study results for tapinarof, plus more.

To keep you up to date with the industry’s latest, we’ve gathered together stories from this week involving glycolic-salicylic acid serum, pediatric multisystem inflammatory syndrome, FDA approvals for dupilumab and minocycline, the latest study results for tapinarof, plus more.

Tapinarof cream demonstrates positive phase 2b results
Dermavant announces the publication of their phase 2b clinical trial investigating tapinarof cream for the treatment of adult plaque psoriasis in the Journal of the American Academy of Dermatology (JAAD).

Filling PPE gaps one visor at a time
Bluestone Sunshields is helping fill the gaps of PPE available to those working on the frontlines of the COVID-19 pandemic by converting their UV ray-blocking visors into clear face shields.

Dupilumab approved by FDA for children with atopic dermatitis
The FDA has approved dupilumab (Dupixent, Sanofi and Regeneron) for the treatment of atopic dermatitis in children ages 6-11 years, making it the first biologic approved for atopic dermatitis in this particular age group.

Amy Paller, M.D., explains multisystem inflammatory syndrome in children
Part three of our interview with Amy Paller, M.D., focuses on the emergence of a multisystem inflammatory syndrome in children (MIS-C), what we know about this novel condition and its relationship to COVID-19.

Glycolic-salicylic acid serum safe, effective
The authors of a recently published commentary report they’ve developed a glycolic and salicylic acid combination serum they say could disrupt traditional use of topical benzoyl peroxide and antibiotics to treat acne.

Scientists identify UV skin cancer trigger
A study from the University of Washington Medicine in Seattle pinpoints one of two lesions that may contribute to the development of UV light-caused skin cancer.

FDA approves first topical minocycline for rosacea
The U.S. Food and Drug Administration has approved FMX103 (ZILXI, Menlo Therapeutics), a topical 1.5% minocycline foam for the treatment of inflammatory lesions of rosacea in adult patients.

How to address patient concerns during COVID-19
Dermatology patients are hungry for information that will ensure their safety during the COVID-19 pandemic, notes Vivian Shi, M.D. In this video, she discusses how to address patients' varying concerns in this uncertain time.

DermYoung, Eden MedSpa launch campaign to help NYC first responders
DermYoung and Eden MedSpa announce the launch of their “Together We Are Love, Together We Will Heal,” campaign, which aims to provide NYC first responders with facials and take-home skincare kits for those experiencing skin damage and irritation due to PPE usage.